Intel Conclusion Acute neurological deficits in the setting of recent mRNA COVID-19 vaccine administration may represent new onset multiple sclerosis Jan 20, 2022 Brian Robert Hyland Leave a comment Share this: Share on Telegram (Opens in new window) Telegram Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X Share on Tumblr (Opens in new window) Tumblr More Share on WhatsApp (Opens in new window) WhatsApp Share on LinkedIn (Opens in new window) LinkedIn Share on Reddit (Opens in new window) Reddit Like Loading... Related
